A Chinese medicine composition for treating ischemic stroke and preparation method thereof
Through the traditional Chinese medicine composition, the decoction of water to eliminate phlegm and remove blood stasis, dilate blood, and regulate platelet hypercoagulation, the problem of poor efficacy in the treatment of ischemic stroke in the prior art was solved, and the patients' neurological function and quality of life were significantly improved. Prevent and treat carotid plaque progress.
Patent Information
- Application Number
- CN202410628881.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-21
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-05-21
AI Technical Summary
The prior art has poor efficacy in the treatment of ischemic stroke, the onset of antiplatelet drugs is slow, and the gastrointestinal tract is highly irritating. Some patients are responsive to clopidogrel, resulting in the problem of unsatisfactory efficacy. .
Develop a traditional Chinese medicine composition, including whole Trichosanthes kirilowii, Pinellia ternata, Tangerine peel, raw Atractylodes macrocephala, whole scorpion, Salvia miltiorrhiza, leech, Cassia seed, chicken blood vine and Acorus granulum, and dilate blood vessels by decoction of phlegm and stasis. , reduce blood flow resistance, regulate platelet hypercoagulation, inhibit thrombosis, and combine with drug carrier preparation methods.
The decoction of phlegm and blood stasis effectively improves blood microcirculation, inhibits thrombosis, significantly improves the symptoms of neurological defects in patients with ischemic stroke, reduces the disability rate, prevents and treats the progression of carotid plaques, and improves the quality of life of patients.
Smart Images

Figure CN118453742B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of traditional Chinese medicines, and more specifically, to a traditional Chinese medicine composition for treating ischemic stroke. Background Art
[0002] Stroke is a disease with high mortality and disability rates worldwide, and is the second leading cause of death after ischemic heart disease. Stroke can be divided into ischemic stroke and hemorrhagic stroke. Ischemic stroke is the most common type of stroke, accounting for about 62% of all strokes worldwide and more than 80% in my country. Due to the limitation of the treatment time window, most patients fail to receive effective treatment in the acute phase of ischemic stroke, resulting in severe neurological deficits. Even if the patients survive, about 75% will have sequelae such as dysphagia and language and motor dysfunction. Sequelae will not only affect the patient's future health and quality of life, but also affect the psychological feelings of the patient and his family, and increase the burden on the family and society. At present, there is still a lack of effective treatment methods in clinical practice. Antiplatelet drugs are mainly used to prevent and treat ischemic stroke. However, oral antiplatelet drugs have the disadvantages of slow onset and high gastrointestinal irritation. Some patients even have resistance, resulting in poor efficacy. Therefore, developing a Chinese medicine composition that is effective in treating ischemic stroke is an urgent problem to be solved in the art. Ischemic stroke seriously endangers people's health. It is one of the main causes of disability or even death in patients. Western medicine mainly treats it by inhibiting platelet aggregation, improving cerebral microcirculation and protecting brain cells, but the clinical efficacy is not ideal.
[0003] Currently, effective treatment measures for ischemic stroke include acute thrombolysis or thrombectomy to recanalize blood vessels and anti-platelet aggregation. However, the application of these treatment measures is limited due to the limitation of the thrombolysis time window and the concern about the complications of thrombolysis. The first-line drugs for anti-platelet therapy are mainly aspirin and clopidogrel, but there are individual differences in the responsiveness of some patients to clopidogrel. The low responsiveness of platelets accelerates the process of atherosclerosis and increases the recurrence rate and mortality rate of ischemic cerebrovascular disease. Therefore, safer and more effective treatment methods are urgently needed. Traditional Chinese medicine has accumulated rich knowledge and experience in the treatment of this disease. Therefore, the present invention uses the advantages of traditional Chinese medicine to make up for the shortcomings in current treatment.
[0004] To this end, we propose a Chinese medicine composition for treating ischemic stroke and a preparation method thereof to solve the above problems. Summary of the invention
[0005] In order to overcome the above-mentioned defects of the prior art, the embodiments of the present invention provide a Chinese medicine composition for treating ischemic stroke and a preparation method thereof, so as to solve the problems raised in the above-mentioned background technology.
[0006] To achieve the above-mentioned purpose, the present invention provides the following technical scheme: a Chinese medicine composition for treating ischemic stroke, comprising the following Chinese medicines in parts by weight: 12-14 parts of whole Trichosanthes kirilowii, 8-10 parts of French Pinellia, 8-12 parts of dried tangerine peel, 12-15 parts of raw Atractylodes macrocephala, 3-5 parts of whole scorpion, 30-60 parts of Salvia miltiorrhiza, 6-10 parts of Leech, 10-30 parts of Cassia seed, 10-15 parts of Millettia reticulata, 12-15 parts of Acorus calamus and a drug carrier.
[0007] In a preferred embodiment, the whole Trichosanthes kirilowii is 12 parts, the French Pinellia is 10 parts, the dried orange peel is 12 parts, the raw Atractylodes macrocephala is 12 parts, the whole scorpion is 5 parts, the salvia miltiorrhiza is 30 parts, the leech is 6 parts, the cassia seed is 30 parts, the Millettia spatholobi is 15 parts and the Acorus gramineus is 12 parts.
[0008] In a preferred embodiment, the drug carrier is selected from any one or more of a filler, a binder, a suspending agent, a wetting agent, a solvent or a flavoring agent.
[0009] A method for preparing a Chinese medicine composition for treating ischemic stroke comprises the following steps:
[0010] S1: Weigh the above drugs according to the proportion;
[0011] S2: Then add 3 to 6 times the total weight of the medicine in water, decoct twice, combine the decoctions, concentrate into an extract, and make a phlegm-removing and blood-stasis-removing water decoction.
[0012] Technical effects and advantages of the present invention:
[0013] 1. Studies have shown that the decoction for removing phlegm and removing blood stasis can dilate blood vessels, dilute blood, reduce blood flow resistance, improve blood microcirculation, inhibit thrombosis by regulating the hypercoagulable state of platelets, and effectively treat stroke;
[0014] 2. The decoction for resolving phlegm and removing blood stasis has the effects of resolving phlegm and removing blood stasis, relaxing muscles and tendons, and regulating internal organs. While improving symptoms, it can effectively prevent and treat the progression of carotid artery plaques into cardiovascular and cerebrovascular diseases such as stroke. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 This is a schematic diagram showing the comparison of neurological deficit function scores before and after treatment according to the first embodiment of the present invention;
[0016] Figure 2 This is a schematic diagram of the statistical analysis results (x±s) of the intima-media thickness (IMT) of two groups before and after treatment in the second embodiment of the present invention;
[0017] Figure 3 This is a schematic diagram of the statistical analysis results (x±s) of the long diameters of two groups of plaques before and after treatment in the second embodiment of the present invention;
[0018] Figure 4 This is a schematic diagram of the statistical analysis (x±s) of blood lipid indicators of two groups before treatment in the second embodiment of the present invention. DETAILED DESCRIPTION
[0019] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0020] Embodiment 1
[0021] A total of 60 outpatients and inpatients from the Affiliated Hospital of Shaanxi Central Hospital from June 2013 to May 2016 were collected. They fully met the inclusion and exclusion criteria. According to the random number table, all patients were randomly divided into a treatment group and a control group, with 30 patients in each group. Inclusion criteria: aged between 40 and 80 years old, conscious; in line with the diagnostic criteria of convalescent stroke of phlegm and blood stasis type in traditional Chinese medicine; in line with the diagnostic criteria of cerebral infarction in the Western medicine "Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China 2010"; no consciousness disorder; signed informed consent.
[0022] Exclusion criteria: patients with TIA and cerebral hemorrhage; patients with cerebral embolism confirmed by clinical examination (caused by brain trauma, brain tumor, metabolic disorder, brain parasitic disease, coronary heart disease, rheumatic heart disease, and other heart diseases combined with atrial fibrillation); patients with impaired consciousness; pregnant women, women in lactation period, patients allergic to the ingredients of the drug; patients with severe primary diseases such as liver (patients whose ALT and / or AST values are 1.5 times higher than normal values), kidney (patients whose SCr levels are 1.5 times higher than normal values), blood system and / or endocrine system diseases, and mental illness; patients who are participating in other clinical trials or have participated in other clinical drug trials that have ended but not exceeded 3 months.
[0023] Treatment method: The control group was given basic Western medicine treatment including aspirin enteric-coated tablets (specification 100 mg × 30 tablets, national medicine standard J20130078) 100 mg, once a day, orally. Patients with hypertension, type 2 diabetes, coronary heart disease, etc. were given corresponding Western medicine treatments such as antihypertensive, hypoglycemic, coronary dilatation, and myocardial nutrition. The medication was taken for a total of 4 weeks. The treatment group took oral phlegm-removing and stasis-removing water decoction in addition to basic Western medicine treatment. Before and after treatment, the neurological deficit scores of the treatment group and the control group were compared according to the National Institutes of Health Stroke Scale. 0 points were normal, the smaller the neurological damage, the lower the score, and the greater the neurological damage, the higher the score.
[0024] The results are as follows: (1) Comparison of neurological deficit scores before and after treatment: the neurological deficit score of the control group was lower after treatment than that before treatment (P < 0.05), and the neurological deficit score of the treatment group was lower after treatment than that before treatment (P < 0.05). After treatment, the neurological deficit score of the treatment group was significantly lower than that of the control group (P < 0.05); (2) Comparison of clinical efficacy after treatment: After the treatment, the control group and the treatment group were compared for clinical efficacy. 6 cases were basically cured, 7 cases were significantly improved, 9 cases were improved, 8 cases were ineffective, and the total effective rate was 73%; 9 cases were basically cured, 8 cases were significantly improved, 11 cases were improved, 2 cases were ineffective, and the total effective rate was 93% in the treatment group. The treatment effect of the treatment group was better than that of the control group.
[0025] From the above, it can be seen that for patients with ischemic stroke in the recovery period, the effect of simple basic treatment with Western medicine is slightly poor, but the clinical effect of the phlegm-removing and stasis-removing prescription is significant. The phlegm-removing and stasis-removing decoction can effectively delay and improve the condition of patients in the recovery period of ischemic stroke, alleviate or even eliminate clinical symptoms, improve patients' neurological deficit symptoms, and reduce patients' disability rate.
[0026] Embodiment 2
[0027] A total of 120 patients with carotid artery plaque confirmed by ultrasound examination who visited the Department of Neurology in our hospital from August 2014 to March 2017 were selected, and patients with severe liver and kidney dysfunction were excluded. The 120 patients were randomly divided into an observation group and a control group; the experimental group had 37 males and 23 females, with an average age of (66.4±7.5) years old. The control group had 35 males and 25 females, with an average age of (66.3±7.2) years old; there was no statistical difference in gender ratio and age between the two groups (P>0.05); all the patients in the group met the TCM syndrome differentiation of "mutual stagnation of phlegm and blood stasis" (refer to the "National Standard of the People's Republic of China·Terminology of Clinical Diagnosis and Treatment of Traditional Chinese Medicine·Syndrome Part").
[0028] The observation group was treated with atorvatin + ultrasound therapy + Huatan Quyu prescription, and the control group was treated with atorvatin + ultrasound therapy. The effects of the two groups were compared after a full course of treatment.
[0029] The results showed that the carotid plaque measurement values and blood lipid indexes of the two groups of patients were significantly improved, and the lipid improvement effect of the observation group was significantly better than that of the control group.
[0030] After treatment, the observation group: (1) the thickness and long diameter of the intima-media layer of the plaque were significantly smaller than those in the control group; (2) the total cholesterol and low-density lipoprotein were lower than those in the control group.
[0031] It shows that the traditional Chinese medicine Huatan Quyu prescription combined with brain ultrasound treatment can intervene in carotid artery plaques. Huatan Quyu prescription has the effects of resolving phlegm and removing blood stasis, relaxing muscles and tendons, and regulating internal organs. While improving symptoms, it can effectively prevent and treat carotid artery plaques from progressing to cardiovascular and cerebrovascular diseases such as stroke.
[0032] The working principle of the invention is: Ischemic stroke is caused by various factors that lead to local brain tissue blood supply disorder, causing local brain tissue ischemia and hypoxia, and then a series of complex pathophysiological cascade reactions occur, including inflammatory reaction, oxidative stress and energy metabolism disorder, leading to neurological damage;
[0033] Traditional Chinese medicine believes that phlegm and blood stasis are crucial in the pathological evolution of ischemic stroke and are the primary pathogenesis of the disease. Zhang Zhongjing believed that "if blood overflows from the collaterals, menstruation will be retained, and blood stasis will cause stroke"; Yan Yonghe pointed out that "internal deficiency leads to blood stasis and causes stroke", and Wang Qingren proposed the "blood stasis" theory and created the Buyang Huanwu Decoction, which is widely used in the treatment of stroke. Zhu Danxi believed that "wetness gathers into phlegm, phlegm generates heat, and heat generates wind". Therefore, Chinese medicine practitioners often choose traditional Chinese medicines that have the effects of promoting blood circulation and removing blood stasis, removing phlegm and turbidity to remove blood stasis and dredge the meridians. Studies have shown that such drugs can dilate blood vessels, dilute blood, reduce blood flow resistance, improve blood microcirculation, and inhibit thrombosis by regulating the hypercoagulable state of platelets;
[0034] In modern times, many doctors advocate treating stroke from the perspective of phlegm and blood stasis. For example, the famous doctor Shen Baopu said, "All diseases are caused by phlegm and blood stasis, and phlegm and blood stasis have the same origin." Guan Youbo, an old Chinese medicine doctor, said, "To treat phlegm, you need to treat blood. If blood is activated, phlegm will naturally dissolve. To treat blood stasis, you need to dissolve phlegm. If phlegm is dissolved, blood stasis will naturally disappear." Phlegm and blood stasis are an important component and become the key pathological crux of ischemic stroke. As pointed out in the New Compendium of Materia Medica, "There is no stroke that is not caused by phlegm and blood stasis." As pointed out in the Miscellaneous Works of Ming Doctors, "Therefore, the ancients discussed the hemiplegia, numbness, soreness and pain caused by stroke without citing other symptoms, but only talked about qi deficiency, dead blood, phlegm and fluid. When talking about the root cause of the disease, they took blood disease and phlegm disease as the root." Phlegm, dampness and blood stasis are generated internally, blocking brain meridians, causing poor circulation of qi and blood, and lack of nourishment to the brain, leading to stroke. Resolving phlegm and unblocking meridians can calm qi and blood, regulate meridians, nourish the brain, and cure stroke. Therefore, a Chinese medicine composition for treating ischemic stroke is developed to improve the patient's motor symptoms and quality of life, and can be used in bed or in combination to improve cerebral blood supply and prevent the progression of the disease.
[0035] There is no record of the disease name "ischemic stroke" in traditional Chinese medicine. It is mainly classified into the categories of "vertigo" and "stroke" in traditional Chinese medicine based on its symptoms and signs. The combination of phlegm and blood stasis is the key to the onset of the disease and runs through the entire disease. If phlegm evil is strong, the function of Qi and blood will fail to rise and fall, and if blood stasis is blocked, the flow of Qi and blood will not be smooth. "Phlegm and blood stasis" are important pathogenic factors in the onset of stroke. Phlegm can cause blood stasis, and blood stasis can be mixed with phlegm. Phlegm and blood stasis are stuck together and affect each other, resulting in this disease. This shows that phlegm and blood stasis are mutually rooted and transformed, and influence each other. The combination of phlegm and blood stasis causes stroke. First, phlegm and blood stasis coexist, and the two exist at the same time and influence each other; second, the transformation of phlegm and blood stasis has a primary and a secondary, and the emergency treatment is the main one. Resolving phlegm means removing blood stasis, and removing blood stasis means removing phlegm.
[0036] Professor Yan Yongmei combined her many years of clinical experience to create the clinical diagnosis and treatment method of resolving phlegm and removing blood stasis.
[0037] Trichosanthes: It has anticoagulant, anti-inflammatory, antioxidant, immunomodulatory, and heart and brain hypoxia improving effects. It can regulate the growth, apoptosis, and migration of vascular endothelial cells, improve the neurological function of patients with cerebral ischemia-reperfusion, increase the activity of SOD in brain tissue, and reduce the content of MDA and NO in the brain.
[0038] Pinellia: Alkaloids are the main active ingredients of Pinellia, which has the function of scavenging oxygen free radicals, especially the strongest scavenging ability for DPPH free radicals;
[0039] Danshen: The main chemical active ingredients are diterpenes, tanshinones and salvianolic acid compounds. Pharmacological studies have shown that the chemical components of Danshen have the effects of scavenging oxygen free radicals, anti-inflammatory factors, and anti-oxidative phosphorylation. It is mainly used clinically to protect cardiovascular and cerebrovascular vessels. Danshen Chuanxiongqin injection reduces the levels of TNF-α and IL-1β in astrocytes by upregulating the expression of MIR-145-5p and inhibiting the expression of PLA2G4A, thereby inhibiting cell activation and inflammatory response;
[0040] Tangerine peel: The main chemical components include flavonoids such as naringin, tangeretin, nobiletin, and dihydronobiletin, which have anti-inflammatory, antibacterial, antioxidant, lipid-lowering, antipyretic, anti-inflammatory, and immune-regulating pharmacological effects;
[0041] Atractylodes macrocephala: The main ingredients include Atractylodes macrocephala polysaccharide and Atractylodes macrocephala lactone, which have neuroprotective, anti-inflammatory, antioxidant, and cell apoptosis inhibition effects. Atractylodes macrocephala polysaccharide can reduce the degree of brain edema after focal cerebral ischemia-reperfusion, reduce nerve cell damage, improve neurological deficits, and play a neuroprotective role;
[0042] Scorpion: The main chemical components include scorpion toxins, peptides, enzymes and non-proteins. Scorpion toxins can relieve various pains such as body pain, visceral pain and cancer pain. In addition, scorpions also have anticoagulant and anti-thrombotic effects.
[0043] Leech: The main chemical active ingredients are hirudin, heparinoids, hirudin, histamine, etc., which have the effects of anti-platelet aggregation, anticoagulation, coagulation, and reducing brain damage. They can regulate lipid metabolism and improve endothelial function by regulating serum cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C) levels and the expression of vascular wall cell-related proteins;
[0044] Cassia seed: mainly includes anthraquinones, naphthopyranones, glycosides, fatty acids, polysaccharides and other ingredients, which have the effects of lowering blood pressure, regulating lipids, antibacterial, antioxidant, and regulating intestinal function;
[0045] Millettia reticulata: mainly contains flavonoids, phenolic acid, sterols, terpenes, lignans, anthraquinones and other chemical components, which have the effects of anti-lipid peroxidation, anti-platelet aggregation, vasodilation and anti-platelet aggregation;
[0046] Acorus calamus: mainly includes volatile oil components such as phenylpropanoids and terpenes, as well as non-volatile components such as alkaloids, flavonoids, and organic acids. It has the effects of anti-anxiety, anti-depression, improving cognitive impairment, lowering blood pressure, and protecting cardiovascular health.
[0047] The phlegm-removing and blood-stasis-removing prescription is composed of whole Trichosanthes, French Pinellia, Tangerine Peel, Atractylodes, Scorpion, Cassia Seed, Acorus Gramineus, Millettia Reticulata, Salvia Miltiorrhiza, Leech, etc.
[0048] In the formula, the Chinese Pinellia tuber is pungent and warm, belonging to the spleen, stomach, and lung meridians, drying dampness and resolving phlegm, and relieving adverse reactions and harmonizing the stomach.
[0049] Tangerine peel is pungent, bitter and warm in nature. It enters the spleen and lung meridians, regulates qi and strengthens the spleen, dries dampness and resolves phlegm. Both herbs are monarch herbs. Their main function is to resolve the effect of "the spleen is the source of phlegm, and the lungs are the organ that stores phlegm".
[0050] Atractylodes macrocephala, sweet, bitter and warm, belongs to the spleen and stomach meridians, and is known as "the first medicine for spleen qi tonifying and spleen strengthening", it strengthens the spleen, replenishes qi and resolves phlegm, and nourishes the acquired foundation;
[0051] Whole Trichosanthes root is sweet, slightly bitter and cold, and enters the lung and large intestine meridians. It clears away heat and opens the chest, resolves phlegm and disperses stagnation. It is good at dispersing stagnation and removing phlegm, and strengthens the role of the main drug in transforming the lung, which is the organ that stores phlegm.
[0052] Danshen, bitter, slightly cold, belongs to the heart, pericardium and liver meridians, cools blood, activates blood circulation, regulates menstruation, removes stasis and relieves pain, and is good at unblocking tendons and veins;
[0053] Leeches are salty, neutral and bitter. They belong to the liver meridian and have strong blood-breaking and blood-stasis-removing power. They are good at treating blood stasis that blocks the blood vessels.
[0054] Earthworms are salty and cold, and enter the liver, spleen, and bladder meridians. They have the functions of clearing away heat and calming asthma, calming the nerves and unblocking the meridians. The medicinal properties of this medicine are wandering, and it is good at unblocking the meridians. The combination of the two medicines can break blood stasis, and the functions of removing wind and unblocking the meridians are stronger. It acts on the liver meridian. The liver stores blood in the body and binds the tendons, so that the blood vessels are filled and the functions of the tendons are exerted, removing dampness and activating blood circulation. Together as a minister drug, it can resolve phlegm, remove blood stasis, invigorate qi and activate blood circulation, and assist the monarch drug in exerting its effects.
[0055] Cassia seed, sweet, bitter, salty, slightly cold, enters the liver and large intestine meridians. It clears away heat, improves eyesight, and calms the liver, and is used to calm the hyperactivity of liver yang and eliminate the disadvantages of blood heat caused by blood circulation;
[0056] Millettia reticulata is bitter, slightly sweet, and warm. It enters the liver and kidney meridians. The "New Reference to Medicinal Pieces" says: "It removes blood stasis, generates new blood, and unclogs the meridians." It removes blood stasis, generates new blood, and dredges the tendons and collaterals, and is a total adjuvant.
[0057] Acorus calamus is pungent, bitter and warm, and it enters the heart and stomach meridians. It can open the mind and refresh the spirit, remove dampness and turbidity to harmonize the stomach and calm the mind, and play the role of a drug. The whole formula is reasonable and rigorous, and it protects the essence of the five internal organs together.
[0058] Finally: The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A Chinese medicine composition for treating ischemic stroke, characterized in that: The invention comprises the following traditional Chinese medicines in parts by weight: 12-14 parts of whole trichosanthes, 8-10 parts of French pinellia, 8-12 parts of dried tangerine peel, 12-15 parts of raw atractylodes, 3-5 parts of whole scorpion, 30-60 parts of salvia miltiorrhiza, 6-10 parts of leech, 10-30 parts of cassia seed, 10-15 parts of millettia reticulata, 12-15 parts of calamus and a drug carrier.
2. A Chinese medicine composition for treating ischemic stroke according to claim 1, characterized in that: The invention comprises 12 parts of whole Trichosanthes kirilowii, 10 parts of French Pinellia, 12 parts of dried orange peel, 12 parts of raw Atractylodes macrocephala, 5 parts of whole scorpion, 30 parts of Salvia miltiorrhiza, 6 parts of Leech, 30 parts of Cassia seed, 15 parts of Millettia spatholobi and 12 parts of Acorus calamus.
3. A Chinese medicine composition for treating ischemic stroke according to claim 2, characterized in that: The drug carrier is selected from any one or more of fillers, binders, suspending agents, wetting agents, solvents or flavoring agents.
4. The method for preparing a Chinese medicine composition for treating ischemic stroke according to claim 1, characterized in that: The following steps are involved: S1: Weigh the above drugs according to the proportion; S2: Then add 3 to 6 times the total weight of the medicine in water, decoct twice, combine the decoctions, concentrate into an extract, and make a phlegm-removing and blood-stasis-removing water decoction.
Citation Information
Patent Citations
Stroke mixture and preparation method thereof
CN108743865A
Traditional Chinese medicine for treating syndromes of wind, fire, phlegm and stasis of acute ischemic stroke
CN111821383A
Compound traditional Chinese medicine for treating convalescent wind-phlegm stasis type ischemic stroke
CN114699489A
